Surrozen (SRZN) Net Income towards Common Stockholders (QoQ) (2020 - 2026)
Surrozen (SRZN) Net Income towards Common Stockholders (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Surrozen |
235,841.47 |
-106.67 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
19.47% |
| Dec 31, 2025 |
83.46% |
| Sep 30, 2025 |
-428.52% |
| Jun 30, 2025 |
335.63% |
| Mar 31, 2025 |
-12.80% |
| Dec 31, 2024 |
-472.18% |
| Sep 30, 2024 |
94.32% |
| Jun 30, 2024 |
-188.86% |
| Mar 31, 2024 |
5.10% |
| Dec 31, 2023 |
12.47% |
| Sep 30, 2023 |
-9.08% |
| Jun 30, 2023 |
31.28% |
| Mar 31, 2023 |
-728.61% |
| Dec 31, 2022 |
87.36% |
| Sep 30, 2022 |
4.32% |
| Jun 30, 2022 |
2.99% |
| Mar 31, 2022 |
3.40% |
| Dec 31, 2021 |
-9.22% |
| Sep 30, 2021 |
-8.20% |
| Jun 30, 2021 |
2.83% |
